Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Atorvastatin Calcium I.P. 20mg Tablets
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹134/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Manufacturing & Quality Standards Atorable 20 Tablet is manufactured by Akums, one of India’s most trusted pharmaceutical manufacturers operating under WHO-GMP compliant facilities. The product follows standardized manufacturing protocols, batch-wise quality checks, and regulated documentation systems to ensure consistent quality and reliability for pharmaceutical trade distribution. Product Overview Atorable 20 Tablet is a branded cardiac care formulation from Cafoli Lifecare’s Cadray division, which is dedicated to cardiac, diabetic, and chronic care medicines. The product is developed for PCD pharma franchise distribution, wholesale supply, and institutional procurement channels across India. The formulation is designed for long-term inclusion in chronic therapy portfolios managed by pharmaceutical distributors and franchise partners. Consistent batch-to-batch formulation quality Accurate dosage and composition labeling Professional-grade Alu-Alu packaging Compliance with Indian pharmaceutical regulations Packaging Details 10 x 10 tablets Alu-Alu blister packing Uniform tablet presentation across batches Secure outer carton with complete regulatory labeling Packaging designed for safe logistics handling and inventory storage Target Trade Segment (B2B) Cardiac PCD Pharma Franchise Partners Pharmaceutical Distributors & Stockists Institutional & Bulk Medicine Suppliers Hospital and Clinic Supply Chains Atorable 20 Tablet is supplied strictly through pharmaceutical trade channels and is not positioned for direct-to-consumer sale. Availability & Supply Reliable stock availability for chronic care portfolios Transparent dispatch timelines GST-compliant invoicing with batch traceability Trade-supportive MOQ options for franchise partners Why Include Atorable 20 in Your Cardiac Portfolio Manufactured by WHO-GMP certified Akums facilities Stable formulation suitable for long-term cardiac therapy portfolios Part of Cafoli Lifecare’s focused Cadray cardiac division Designed for sustainable distributor and franchise growth Backed by ethical marketing and compliance-driven practices
Atorable 20 Tablet is manufactured by Akums, one of India’s most trusted pharmaceutical manufacturers operating under WHO-GMP compliant facilities. The product follows standardized manufacturing protocols, batch-wise quality checks, and regulated documentation systems to ensure consistent quality and reliability for pharmaceutical trade distribution.
Atorable 20 Tablet is a branded cardiac care formulation from Cafoli Lifecare’s Cadray division, which is dedicated to cardiac, diabetic, and chronic care medicines. The product is developed for PCD pharma franchise distribution, wholesale supply, and institutional procurement channels across India.
The formulation is designed for long-term inclusion in chronic therapy portfolios managed by pharmaceutical distributors and franchise partners.
Atorable 20 Tablet is supplied strictly through pharmaceutical trade channels and is not positioned for direct-to-consumer sale.
Possible side effects include muscle pain, weakness, headache, and digestive discomfort. Rarely, serious side effects like muscle damage (rhabdomyolysis) or liver problems may occur. Contact your healthcare provider if you experience unexplained muscle pain, tenderness, or jaundice.
Used to treat high cholesterol, mixed lipid disorders, and to lower the risk of cardiovascular complications in patients with risk factors such as diabetes, hypertension, or existing heart disease.
Disclaimer: This product information is intended solely for pharmaceutical trade professionals, PCD pharma franchise partners, distributors, and institutional buyers. Atorable 20 Tablet is not promoted for direct consumer sale. All information is provided in compliance with applicable Indian pharmaceutical regulations.
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Atorvastatin Calcium 20mg Tablet has strong demand in the cardiology and chronic care segment, making it a core product for medical distributors, wholesalers, and pharma franchise partners focusing on lipid management and cardiovascular prevention portfolios.
Medical distributors and agencies can benefit from consistent demand for management of high cholesterol (dyslipidemia), prevention of heart attack, stroke, and long-term cardiovascular risk reduction. Atorvastatin helps reduce LDL cholesterol and supports heart and vascular health, strengthening a reliable cardiology product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Atorvastatin Calcium IP 20mg Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from stable chronic prescription demand, cardiologist preference, long-term therapy usage, strong repeat sales, reliable supply chain support, and good margins when partnering for this cardiovascular product.
Medical distributors, stockists, and wholesalers interested in this tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, pricing, and distribution support.